Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

OMX Europe Venture Fund

Venture Capital France ·Founded 2019

Overview

OMX Europe Venture Fund is a European venture capital fund managed by Mérieux Equity Partners and Korys, focusing on investments in innovative companies within the life sciences sector. The fund is sponsored by Korys and Mérieux Développement, with Korys acting as the primary advisor. Established in 2019, the fund has a size of €100 million and primarily invests in early-stage companies, particularly in the seed stage. It operates across Europe, the United States, and Canada, with a geographical focus on Belgium, France, Germany, the Netherlands, the United Kingdom, the United States, and Canada. The fund's investment strategy includes minority equity stakes, with a minimum investment of €2.5 million and a maximum of €10 million per company. The fund's sectoral preference lies in the biotechnology and life sciences industries, encompassing areas such as pharmaceuticals, medical devices, diagnostics, and various medical research fields. Its investment approach combines equity participation and convertible bond loans, aiming to support the growth and development of innovative companies in the life sciences sector.

Investment Focus

Minority equity participation
Investment size between €2.5 million and €10 million per company
Focus on early-stage companies in the life sciences sector

Reach OMX Europe Venture Fund directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about OMX Europe Venture Fund

What sectors does OMX Europe Venture Fund invest in?

OMX Europe Venture Fund invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in France. OMX Europe Venture Fund is listed as a venture capital in the ConnectSafely investor database.